文献速递神经康复

外骨骼辅助拟人运动训练用于卒中后上肢康复的初步随机对照试验

Exoskeleton-Assisted Anthropomorphic Movement Training (EAMT) for Poststroke Upper Limb Rehabilitation: A Pilot Randomized Controlled Trial.
PubMed 文献 · Arch Phys Med Rehabil · 2021-06-24

该单盲初步随机对照试验纳入20例首次单侧亚急性卒中偏瘫患者,比较外骨骼辅助拟人运动训练(EAMT)与常规上肢治疗(均为45分钟/天、5天/周、共4周)的可行性与疗效。EAMT可行且安全,FMA-UE和MBI改善显著优于对照组,但ARAT组间差异不显著。

要点

  • EAMT在亚急性卒中偏瘫患者中可行、可接受且安全,仅2例出现可耐受的肌肉疲劳。
  • EAMT组FMA-UE变化分较对照组高4.30分(P=.04),MBI高8.70分(P=.03)。
  • ARAT变化分组间差异不显著(P=.18),需更大样本随机对照试验确认。

核心结论

  • EAMT是可行的康复方法,可能改善卒中后上肢运动损伤、日常生活活动能力和运动学表现。
  • 需开展样本量充足的随机对照试验确认初步结果并探索EAMT可能的作用机制。

研究设计与样本

  • 单盲初步随机对照试验,在卒中康复住院单元开展。
  • 纳入20例因首次、单侧、亚急性卒中导致偏瘫且FMA-UE评分为8-47分的患者。
  • 外骨骼组接受EAMT任务特异性训练,对照组接受常规上肢治疗,两组强度、频率和时长相同:每日45分钟、每周5天、共4周。

主要发现

  • 20例亚急性卒中患者全部完成所有治疗 session,EAMT可行且可接受。
  • EAMT的招募率、保留率和所需治疗师数量与其他机器人试验相比可接受。
  • EAMT安全,除2例参与者出现可耐受的肌肉疲劳外无不良事件。
  • FMA-UE变化分组间差异显著(差值4.30分,P=.04),MBI变化分组间差异显著(差值8.70分,P=.03),均利于EAMT。
  • ARAT变化分组间差异不显著(P=.18);接受EAMT的参与者治疗后运动学指标显著改善(P<.01)。

关键数值与推荐

  • FMA-UE纳入标准为8-47分。
  • 两组治疗均为每日45分钟、每周5天、共4周。
  • FMA-UE变化分组间差值4.30分(P=.04),MBI变化分组间差值8.70分(P=.03)。
  • ARAT变化分组间比较P=.18,运动学指标治疗前后比较P<.01。

临床怎么用

  • 对符合FMA-UE 8-47分的首次单侧亚急性卒中偏瘫患者,可考虑EAMT作为上肢康复选项。
  • EAMT可按每日45分钟、每周5天、共4周的模式实施,需关注可耐受的肌肉疲劳。
  • EAMT可能改善上肢运动损伤和日常生活活动能力,但ARAT所反映的上肢功能改善尚不明确。

局限性

  • 为初步随机对照试验,样本量仅20例。
  • 原文指出需样本量充足的随机对照试验确认结果并探索作用机制。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To investigate the feasibility of exoskeleton-assisted anthropomorphic movement training (EAMT) and its effects on upper extremity motor impairment, function, and kinematics after stroke. DESIGN: A single-blind pilot randomized controlled trial. SETTING: Stroke rehabilitation inpatient unit. PARTICIPANTS: Participants with a hemiplegia (N=20) due to a first-ever, unilateral, subacute stroke who had a score of 8-47 on the Fugl-Meyer Assessment for Upper Extremity (FMA-UE). INTERVENTIONS: The exoskeleton group received EAMT therapy that provided task-specific training under anthropomorphic trajectories and postures. The control group received conventional upper limb therapy. For both groups, therapy was delivered at the same intensity, frequency, and duration: 45 minutes daily, 5 days per week, for 4 weeks. MAIN OUTCOME MEASURES: Primary outcome: feasibility analysis. SECONDARY OUTCOMES: FMA-UE, Action Research Arm Test (ARAT), modified Barthel Index (MBI), and kinematic metrics during exoskeleton therapy. RESULTS: Twenty participants with subacute stroke were recruited and completed all therapy sessions. EAMT therapy was feasible and acceptable for the participants. The recruitment rate, retention rate, and number of therapists required for EAMT therapy were acceptable compared with other robotic trials. EAMT was determined to be safe, as no adverse event occurred except tolerable muscle fatigue in 2 participants. There were significant between-group differences in the change scores of FMA-UE (difference, 4.30 points; P=.04) and MBI (difference, 8.70 points; P=.03) in favor of EAMT therapy. No significant between-group difference was demonstrated for the change scores of ARAT (P=.18). Participants receiving EAMT showed significant improvements in kinematic metrics after treatment (P<.01). CONCLUSIONS: Our results indicate that EAMT is a feasible approach and may improve upper extremity motor impairment, activities of daily living, and kinematics after stroke. However, fully powered randomized controlled trials are warranted to confirm the results of this pilot study and explore the underlying mechanisms by which EAMT therapy might work.

来源:Arch Phys Med Rehabil,查看原文。版权归原作者所有。

引用

  1. Chen ZJ, He C, Guo F, et al. Exoskeleton-Assisted Anthropomorphic Movement Training (EAMT) for Poststroke Upper Limb Rehabilitation: A Pilot Randomized Controlled Trial. Arch Phys Med Rehabil. 2021. PMID: 34174225. doi:10.1016/j.apmr.2021.06.001

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。